MedTrace Logo

Xenogenous Collagen Matrix Graft With or Without Enamel Matrix Proteins Derivative for Root Coverage

NCT02456337 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2016-10-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the reduction of gingival recession of single Miller Class I and II defects treated by coronally advanced flap with subepithelial porcine collagen matrix graft and / or enamel matrix proteins.

Conditions

  • Gingival Recession

Interventions

DEVICE

Mucograft

Coronally advanced flap associated to Xenogenous collagen matrix graft (mucograft) for the treatment of gingival recessions Miller Class I or II.

DEVICE

Emdogain

Coronally advanced flap associated to Enamel Matrix Derivative (Emdogain) for the treatment of gingival recessions Miller Class I or II.

PROCEDURE

Coronally Advanced flap

Coronally advanced flap for the treatment of gingival recessions Miller Class I or II.

Sponsors & Collaborators

  • University of Sao Paulo

    collaborator OTHER

  • University of Campinas, Brazil

    lead OTHER

Principal Investigators

  • Enilson A Sallum, PhD · University of Campinas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-09-30
Completion
2016-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02456337 on ClinicalTrials.gov